Latest 10-Q quarterly reports

Trailblazer Acquisition Corp. reports net income of $2.27 million for Q1 2026, primarily from interest on trust account investments, while continuing its search for a business combination.

Archimedes Tech SPAC Partners III Co. reports net income of $1.57 million for Q1 2026, driven by interest income from its trust account, as it continues to search for a business combination.

Talon Capital Corp. reports net income of $1.97 million for Q1 2026, driven by interest income from its trust account, while continuing its search for a business combination.

SpyGlass Pharma, Inc. reported its first-quarter 2026 financial results, highlighting progress in its Phase 3 clinical trials for the BIM-IOL System aimed at treating glaucoma.

Bitcoin Infrastructure Acquisition Corp. reports net income of $1.62 million for Q1 2026, primarily driven by interest income, as it continues its search for a business combination.

Synlogic Inc. reported a net income of $681,000 for the first quarter of 2026, a significant increase from the prior year, as the company continues its strategic review process.

LaFayette Acquisition Corp. reports net income of $839,928 for Q1 2026, primarily driven by interest income from its trust account, while continuing its search for a business combination.

Oncolytics Biotech reported a net loss of $9.24 million for Q1 2026, with significant increases in R&D and G&A expenses, while cash reserves remain a concern for long-term operations.

P3 Health Partners Inc. filed its Form 10-Q for the quarter ended March 31, 2026, reporting a net income of $3.04 million, a significant improvement from a net loss of $44.25 million in the prior year period.

Alaska Silver Corp. reported a net income of $1.23 million for the first quarter of 2026, a significant turnaround from a loss in the prior year, primarily driven by a gain on derivative warrant liability revaluation.

Biofrontera Inc. announced its first quarter 2026 financial results, reporting a 17.4% increase in net product revenue to $10.1 million, driven by higher Ameluz sales.

T Stamp Inc. reported a 38.75% increase in net revenue for Q1 2026, driven by its S&P 500 bank customer, but also saw its net loss widen.

GlobeX AI Hong Kong Holding Limited and Hebei Huanzhou Automobile Sales Co., Ltd. have signed a strategic cooperation agreement for mass-production-oriented parts procurement and engineering services for their 'Super One' cooperative model.

MapLight Therapeutics, Inc. reported a net loss of $60.7 million for the first quarter of 2026, with increased R&D expenses driving the results.

Park Dental Partners reports a net loss of $390,000 for Q1 2026, a significant shift from the prior year's profit, driven by increased operating costs and share-based compensation.

Fennec Pharmaceuticals announced first quarter 2026 results, with PEDMARK net sales reaching $15.1 million, a 73% increase year-over-year, driven by market penetration and sales force expansion.

Emmis Acquisition Corp. reports on its financial condition and operations for the quarter ended March 31, 2026, highlighting trust account balances and administrative costs.

Northpointe Bancshares, Inc. announced a significant increase in net income available to common stockholders for the first quarter of 2026, driven by robust loan growth and improved net interest margin.

AIRO Group Holdings reported a significant decrease in revenue for the first quarter of 2026, primarily driven by lower order volumes in its Drones segment.

Jefferson Capital, Inc. reported a decrease in net income for the first quarter of 2026 compared to the prior year, driven by increased operating expenses, particularly in servicing and salaries.

VolitionRx Limited reported a significant increase in revenues driven by product sales, but also a wider net loss due to increased operating expenses and non-cash accounting charges.

American National Group Inc. reported a net loss of $7 million for Q1 2026, a significant improvement from the prior year's loss, driven by reduced market risk benefit expenses and increased investment income.

Nexentis Technologies Inc. reported a net loss of $6.59 million for Q1 2026, impacted by a $6.3 million goodwill impairment charge related to its MitoCareX subsidiary, alongside strategic divestitures and ongoing development in biotechnology and renewable energy.

Barfresh Food Group reports a significant revenue increase in Q1 2026 driven by the Arps Dairy acquisition, though net loss persists.

AVITA Medical's Q1 2026 filing details revenue growth, operational expense reduction, and a new $60 million credit facility, while acknowledging ongoing going concern doubts.

Fossil Group reported a net loss of $0.8 million for Q1 2026, an improvement from the prior year's loss, despite a 3.6% decrease in net sales.

RenovoRx announces significant revenue acceleration in Q1 2026, driven by increased commercial adoption of its RenovoCath device, while its TIGeR-PaC trial nears enrollment completion.

MariMed Inc. reported a 4.2% increase in revenue for Q1 2026, reaching $39.5 million, while net loss attributable to common stockholders narrowed to $3.8 million.

TopPoint Holdings reported an 8% revenue increase in Q1 2026 driven by import growth, but net loss expanded due to rising costs.

Drugs Made in America Acquisition II Corp. reports Q1 2026 results, with net income driven by trust account interest, while continuing search for a business combination.